Kebuzone or ketophenylbutazone
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384612This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C19H18N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4VD83UL6Y6, chemically known as 3,5-pyrazolidinedione, 1,2-diphenyl-4-(3-oxobutyl)- but generally known as kebuzone, which bears US NIH Compound Identifier 3824. European Medicines Agency schedules Kebuzone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08363MIG. The term KEBUZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). World Health Organization schedules kebuzone in its Anatomical Therapeutic Chemical (ATC) Classification. KEBUZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Kebuzone or ketophenylbutazone bears US NLM identifiers UMLS ID C0064324 and NCI Concept Code C79126. SMILES: CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3.
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.